Select a Region North America


Adam Hardy

Vice President, Commercial Operations



Adam Hardy is a leader in the pharmaceutical industry, having worked in the industry for over 15 years in both European and US-based organizations. This experience includes working in all phases of pharmaceutical R&D, including leading global teams in clinical development and commercialization companies. As such, Adam is highly experienced in the drug development and commercialization process and driving the development of optimal solutions for biotechnology and pharmaceutical companies.

At EVERSANA, Adam has brought his expertise to the development of budget constructs for global COMPLETE Commercialization projects. Adam holds a Ph.D. in Pharmacology from the University of Bristol in the UK.

Articles by Adam Hardy

Establishing the Patient Access Mission During Clinical Development

An inescapable but disappointing characteristic of pharmaceutical research and development is that at the end of a process costing billions of dollars, the majority of launches fail to reach expectations. The ultimate tragedy of this is that the fundamental purpose of pharmaceutical R&D is undermined: patients are either delayed in receiving the best products to […]

Considering Commercial Success During Clinical Development: Maintaining a Global Perspective

Although commercial success is the ultimate goal of pharmaceutical research and development (R&D), many new treatments do not meet expectations and fail to achieve broad global reimbursement after initial regulatory approval., This causes therapies to underperform across international markets and, more importantly, limits access for patients in need. For example, only 56% of all new drugs approved by the European Medicines Agency (EMA) […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.